managing editor
julia aalbers
Tel: 021 976 4378
Fax: 086 610 3395
e-mail:
Production Editor
SHAUNA GERMISHUIZEN
Tel: 021 785 7178
Fax: 086 628 1197
e-mail:
Editorial Assistant &
Circulation
ELSABÉ BURMEISTER
Tel: 021 976 8129
e-mail:
development editor
GLENDA HARDY
Cell: 071 8196 425
e-mail:
Production
Co-ordinator
WENDY WEGENER
Tel: 021 976-4378
e-mail:
GAUTENG CONTRIBUTOR
PETER WAGENAAR
Cell 082 413 9954
e-mail:
CONTENT MANAGER
Michael Meadon (Design Connection)
Tel: 021 975 3785
Fax: 0866 557 149
e-mail:
The
Cardiovascular Journal of Africa
,
incorporating the
Cardiovascular
Journal of South Africa
,
is published 10
times a year, the publication date being
the third week of the designated month.
Copyright:
Clinics Cardive Publishing (Pty) Ltd.
Layout:
Martingraphix
Printer:
Durbanville Commercial Printers
ONLINE SERVICES:
Design Connection
All submissions to CVJA are to be
made online via
Electronic submission by means of an
e-mail attachment may be considered
under exceptional circumstances.
Postal address: PO Box 1013,
Durbanville, 7551
Tel/Fax: 021 976 8129
Int.: +27 21 976 8129
e-mail:
Electronic abstracts available on Pubmed
Audited circulation
Full text articles available on:
co.za or via
; for access
codes contact
Subscriptions for 10 issues:
To subscribe to the journal or change
your postal address, e-mail
South Africa: R650 (excl VAT)
Overseas: R1306
Online subscription: R200
The views and opinions expressed in the
articles and reviews published are those
of the authors and do not necessarily
reflect those of the editors of the Journal
or its sponsors. In all clinical instances,
medical practitioners are referred to the
product insert documentation as approved
by the relevant control authorities.
CONTENTS
VOL 23, NO 9. OCTOBER 2012
Review Articles
507
Neo-intimal hyperplasia, diabetes and endovascular injury
D Kruger
512
Obesity and its health impact in Africa: a systematic review
B Adeboye • G Bermano • C Rolland
Drug Trends
European Society of Cardiology congress 2012, Munich, Germany
522
New ESC guidelines on atrial fibrillation accept reality of next generation of anti-coagulants
J Aalbers
524
Renal denervation in Symplicity trials and real-life setting continue to show significant
blood pressure reduction in all treatment groups
J Aalbers
525
Rivaroxaban in acute coronary syndromes and atrial fibrillation: rivaroxaban shown to
reduce cardiovascular deaths in STEMI patients
J Aalbers
528
Ivabradine reduces total hospital burden in heart failure
J Aalbers
528
GARFIELD: a window on the real-life treatment of atrial fibrillation. South Africa joins the
GARFIELD registry
J Aalbers
PUBLISHED ONLINE
(
Available on
and in Pubmed)
Case Reports
e1
Acute anterior myocardial infarction in an 85-year-old male
patient, complicated by the deadly duo: ventricular septal
rupture and pseudoaneurysm
AC Aykan • R Zehir • CY Karabay • S Cakal • N Poci • K Sönmez
e4
Giant pseudoaneurysm of the left axillary artery following
a stab wound
M Fokou • VC Eyenga • A Chichom Mefire • ML Guifo •
JJ Pagbe • W Sandmann
e7
Acute ST-elevation inferior myocardial infarction in a patient
with a non-obstructive mechanical mitral valve thrombosis
AC Aykan • M Özkan • NE Duran • M Yildiz
e9
Prolonged coagulopathy related to coumarin rodenticide in
a young patient: superwarfarin poisoning
HA Cakmak • S Altay • GC Boz • S Koca • Y Velibey
HEALTHCARE
